In terms of treatment monitoring and disease course, the decrease in or even disappearance of SARS-CoV-2 IgM concentration and the increase in SARS-CoV-2 IgG concentration indicate that patients gradually recover and develop immunity to the pathogenicity of COVID-19. This evidence concerns the gene CD40LG and COVID-19.